Clinical Trial Update: Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy

View source ↗

Summary

This update describes the rationale and study design for the PFB-03 trial evaluating 18F-FAPI-PET/CT for detecting axillary lymph node metastasis in breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-FAPI-PET/CT (18F-labeled fibroblast activation protein inhibitor positron emission tomography/computed tomography imaging tracer)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING